✦ LIBER ✦

Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension

✍ Scribed by M. G. Bianchetti; P. Weidmann; K. Boehringer; L. Link; H. Schiffl; C. Beretta-Piccoli; J. P. Colombo

Publisher: Springer
Year: 1982
Tongue: English
Weight: 852 KB
Volume: 23
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00637493

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pinacidil, a new vasodilator, in the tre

Pinacidil, a new vasodilator, in the treatment of patients with moderate to severe hypertension

✍ K. Koliopoulos; D. E. Papadoyannis; N. B. Karatzas 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 280 KB

Pinacidil, a new vasodilator, in the tre

Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension

✍ V. D'Arcy; M. Laher; D. McCoy; P. Sullivan; C. H. Walsh; M. P. Hickey 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 328 KB

Evaluation of celiprolol, a new cardiose

Evaluation of celiprolol, a new cardioselective beta1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly

✍ K. D. Lamon 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 499 KB

Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity. The studies discussed were designed to assess celiprolol's pharmacokinetic disposition, its efficacy versus placebo and other beta blockers, its relative safety profile, and its therapeutic rati

Chronic treatment with the new potent va

Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: Effects on blood pressure, endocrine function, sodium and plasma volume

✍ M. Grimm; P. Weidmann; A. Meier; H. Schiffl; W. H. Ziegler 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 811 KB

A comparison of lisinopril and nifedipin

A comparison of lisinopril and nifedipine in the treatment of mild to moderate hypertension

✍ B. Rogstad 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 294 KB

Comparison of once daily felodipine 10 m

Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension

✍ W. Koenig; M. Sund; L. Binner; R. Hehr; J. Rosenthal; V. Hombach 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 309 KB

The efficacy of extended release felodipine 10 mg (ER) o.d., a new dihydropyridine calcium antagonist, and 25 mg hydrochlorothiazide (HCTZ) o.d. have been compared in a randomized, double-blind, crossover trial in 28 mildly to moderately hypertensive subjects (supine diastolic blood pressure, BP, gr